The package insert of the medicine Reducofen

the package insert of the medicine Reducofen. Active principles Fenofibrate Micronized.

what For?

In adults REDUCOFEN is indicated in hypercholesterolemia type IIa and IIb, and/or hypertriglyceridemia endogenous (type IV) or associated (types IIb and III):
when the diet, strictly followed has proved to be ineffective;
when the cholesterol in the blood, after the diet, remains high and/or there are risk factors involved.


When should I not use?

REDUCOFEN should never be used in liver and kidney failure severe; children; association with HMG Coredutase or other fibrates, except when under medical prescription (see Drug interactions).


How to use?

1 capsule a day, during the lunch or dinner. REDUCOFEN, associated with a proper diet, is a symptomatic treatment of long duration, which must be regularly monitored.

Keep the medicine at room temperature (15º to 30ºC); protect from light and moisture.

Provided that you followed the care of conservation, the term of validity of REDUCOFEN is 36 months from the manufacturing date (see outer packaging).

Side Effects

What are the evils that can cause me?

Problems gastrointestinal, such as digestion difficult, allergic reactions to the skin, elevation transient transaminases, muscular pains.

Warnings and Precautions

what should I know before using?

Pregnancy: the fibrates are not indicated for pregnant women, except in the cases of hypertriglyceridemia severe (> 10 g/l), is not corrected by diet, under risk of causing acute pancreatitis. Lactation: it is recommended to women who really need to receive the medicine after birth, not breastfeed.

If, after a period of 3-6 months of treatment, no evidence of a fall in satisfactory levels blood lipid, we need to evaluate the convenience of a therapy, supplemental or substitutive. Have been reported increases in transient in transaminases in some patients. It is advisable to monitor on a quarterly basis the serum transaminases during the first year of treatment and to assess the advisability of suspending the same, when the activity of the TGP to overcome the rate of 100 mU, or discontinue treatment in the cases in which the increase in the levels of aspartate aminotransferase (AST) and alaninoaminotransferase (ALT) exceed 3 times the upper limit of normal range.


what to do if someone use a larger amount than is recommended?

there is No specific treatment for overdose with fenofibrate. General care of the patient are indicated, including monitoring of vital signs and observation of the clinical picture. If indicated, elimination of the drug is not absorbed can be achieved by emesis or gastric lavage, precautions usual must be observed to maintain the airway. The fenofibrate binds highly to plasma proteins, thus, hemodialysis is not considered.